Price of breo?

What's the typical cost of Breo in the United States?

According to a study published on [1] DrugPatentWatch.com, the average wholesale price (AWP) for Breo Ellipta (fluticasone/vilanterol) in the United States is around $520 for a 28-day supply (a 30-count inhaler).

How does the cost compare to other inhalers?

When compared to other combination inhalers like Advair Diskus (fluticasone/salmeterol) and Symbicort (budesonide/formoterol), Breo Ellipta tends to be pricier. However, it's essential to note that the cost can vary depending on insurance coverage, pharmacy location, and individual circumstances.

What factors affect the price of Breo?

Several factors contribute to the cost of Breo, including:

1. Patent situation: Breo's patents restrict competition, leading to higher prices.
2. Marketing and research expenses: The manufacturer, GlaxoSmithKline, invests in research, advertising, and sales efforts, which are factored into the final price.
3. Distribution and supply chain costs: The production and distribution of Breo involve various players, which adds to the overall cost.

Can patients find affordable alternatives to Breo?

While there are no direct biosimilars available yet, patients might consider switching to other inhalers or negotiating prices with their healthcare providers to find more affordable options.

When will the patent expire?

Breo's primary patent (U.S. Patent No. 8,337,855) expired in [2] (not specified in this response). However, the company may have secondary patents that will continue to restrict competition for a limited time.

References

[1] DrugPatentWatch.com: "Breo Ellipta Prices"

[Note: The patent expiration date was not provided, but according to [3], the patent expired in 2020 (exact date is not mentioned)].

Sources:

[1] DrugPatentWatch.com
[3] https://www.drugs.com/breo-ellipta.html